Brian Abraham Email & Phone Number

Washington, DC, US

Chicago, IL, US

• Lead the development and execution of market access and patient services strategies and tactics for commercial launches of medical technology and biopharmaceutical products in multiple therapeutic areas, including.
• Manage cross-functional teams (eg, Insights, Marketing, Value & Evidence, Account Management, Revenue Management, Patient Services) to prepare partner companies for commercial launch of their products
• Develop, implement and manage payer policy strategies based on primary and secondary research to ensure maximum access for new products and to streamline payer reimbursement
• Lead coding, coverage and payment policy strategies and execution, including development and submission of coding and coverage documentation to authoritative bodies (e.g., American Medical Association, Centers for.
• Seek unique and uncharted coverage and reimbursement pathways for emerging oncolytic and other technologies and work with stakeholders, including CMS, to advocate for these opportunities
• Lead evidence generation strategies to ensure data supports utilization of product(s) at launch and throughout the lifecycle

Chicago, IL, US

• Led market access and reimbursement strategic initiatives for biopharmaceutical, medical device, and digital health clients based on public and private payer policies
• Developed policy position papers and guidance documents to help clients understand the unique challenges and issues regarding market access and reimbursement for their products, including in the oncology space.
• Provided clients with an understanding of patient/provider support needs particular to oncologic products, including distribution and gross-to-net considerations
• Developed strategic market access and reimbursement plans, including coverage, coding and payment components, for clients based on landscape and policy assessments for new and existing products
• Advised clients and executed coding strategies to obtain optimal reimbursement for products entering the market
• Worked across the organization to ensure client needs were addressed through management consulting, national accounts, and distribution workstreams

Chicago, IL, US

• Consulted to biopharma and medical device clients with strategic planning and execution around public and private health policy issues, value propositions, health outcomes planning, and evidence assessment and.
• Led multi-faceted project for medical device client that included complete overhaul of pricing strategy, vendor registration with major payers, and coding strategy. Led client through exercise to shift paradigms of.
• Developed strategy document regarding coverage and coding for small manufacturer with a drug-device combination product that would be utilized in multiple settings of care
• Led clients through product and procedure coding application process to ensure unique identification of the product or procedure for medical billing. The process included detailed interaction with client stakeholders.
• Conducted in-depth analysis of literature regarding a client’s medical device, resulting in discussions with payers on how to better position the product for coverage.
• Worked across internal departments to identify and contact clients with potential market access needs and inform them of life sciences consulting services of which they may be unaware

• Advised medical device and biopharma clients on value-based coverage, coding, and payment policies so they understood and benefited from these dynamic drivers in the healthcare system.Other clients include trade.
• Analyzed situation and developed strategy to help major biopharmaceutical company align its contracting function with other company stakeholders to achieve desired efficiencies and outcomes in the bidding process
• Developed and presented multiple public and private payer policy assessments, recommendations, and multi-year strategic plans for drug and device manufacturers to inform their decisions on market access planning pre.
• Guided clients through policy and evidence reviews to help them determine the best methods of leveraging existing data and planning for clinical studies to help ensure public and private insurer positive determinations.
• Leveraged relationships with CMS to yield favorable coverage outcome for client company on issue before the agency
• Conducted comprehensive coverage analysis and updated customer materials for device company; subsequently helped company establish a customer-facing reimbursement assistance service offering

Houston, TX, US

Nuo Therapeutics, Inc. developed and commercialized individualized wound care therapies. The Company’s flagship product, Aurix, is a biodynamic hematogel that harnesses a patient’s innate regenerative ability to stimulate healing in a variety of chronic wounds. My work centered around the successful launch of Aurix through Medicare's Coverage with Evidence.

• The Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA), is the leading organization and collective voice of medical imaging equipment manufacturers.
• Led a coalition to develop white paper to change Medicare policy on non-covered positron emission tomography (PET) procedures. Co-authored proceedings paper in peer-reviewed journal. As a result, CMS expanded coverage.
• Directed collaboration with CMS on clinical trial and evidence development policy initiatives, including development of testimony for public hearing on changing clinical trial policies, which ultimately was the basis.
• Led alliances with stakeholder organizations, including professional societies and patient groups, to ensure appropriate coverage and payment of members’ products
• Developed and implemented a stakeholder workshop with 50+ participants from industry, government, and academia to demonstrate to CMS that covering members’ products would lead to improved patient care
• Initiated formal dialog with Food and Drug Administration (FDA) to ensure members’ medical imaging products received appropriate consideration

Louvain-la-Neuve, BE

Established and built the reimbursement program as part of the launch team for molecular tracers.

Led patient services efforts for multiple clients

Gaithersburg, Maryland, US

Led the reimbursement efforts to ensure marketed products received appropriate coverage policies and payments in the public and private markets.

Gaithersburg, Maryland, US

Promoted from Sr. Manager 2004

Princeton, New Jersey, US

Developed, launched, and managed reimbursement support programs for emerging and existing pharmaceutical products to ensure wide access to these products for patients and physicians

Bachelor Of Arts (B.A.), Government

Master Of Public Administration - Mpa, Finance, Organizational Management